Pyridoxamine Traps Intermediates in Lipid Peroxidation Reactions in Vivo

This publication has 32 references indexed in Scilit:

• The AGE inhibitor pyridoxamine inhibits lipemia and development of renal and vascular disease in Zucker obese rats
  Kidney International, 2003
• The simultaneous quantification of cytochrome P450 dependent linoleate and arachidonate metabolites in urine by HPLC-MS/MS
  Journal of Lipid Research, 2002
• Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat
  Kidney International, 2002
• Microalbuminuria in type 1 diabetes: Rates, risk factors and glycemic threshold
  Kidney International, 2001
• Plasma lipids and risk of developing renal dysfunction: The Atherosclerosis Risk in Communities Study
  Kidney International, 2000
• Amadorins: Novel Post-Amadori Inhibitors of Advanced Glycation Reactions
  Biochemical and Biophysical Research Communications, 1999
• Diabetic dyslipidemia
  The American Journal of Cardiology, 1998
• Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: Is there oxidative stress in uremia?
  Kidney International, 1998
• Role of the Maillard Reaction in Diabetes Mellitus and Diseases of Aging
  Drugs & Aging, 1996
• The Advanced Glycation End Product, N∊-(Carboxymethyl)lysine, Is a Product of both Lipid Peroxidation and Glycoxidation Reactions
  Journal of Biological Chemistry, 1996